FIELD: medicine.
SUBSTANCE: invention relates to novel antiviral medication, possessing antiviral activity with respect to highly pathogenic virus of avian influenza A/chicken/Kurgan/05/2005 (A/H5N1). Claimed antiviral medication represents culture fluid or lysate of cells of Bacillus thuringiensis strain FSIS SRC VB "Vector" B-1069 or Bacillus thuringiensis strain FSIS SRC VB "Vector" B-1073 or strain of Bacillus thuringiensis FSIS SRC VB "Vector" B-1091.
EFFECT: invention makes it possible to increase efficiency of antiviral medications.
3 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Bacillus thuringiensis BACTERIA STRAIN EXHIBITING ANTIVIRAL AND ANTI-CANDIDA ACTIVITY (VERSIONS) | 2009 |
|
RU2405035C1 |
| STRAIN OF BACTERIA Bacillus thuringiensis, NEUTRALISING INFECTIOUS ACTIVITY OF HUMAN INFLUENZA VIRUS A/H3N2 (VERSIONS) | 2013 |
|
RU2551236C1 |
| STRAIN OF BACTERIA Serratia species WHICH IS PRODUCER OF EXTRACELLULAR RIBONUCLEASE AND DEOXYRIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2528064C1 |
| ANTIVIRAL AGENT BASED ON SERRATIA-FAMILY BACTERIA NUCLEASE | 2014 |
|
RU2580242C2 |
| STRAIN OF BACTERIA Serratia plymuthica HAVING ANTIVIRAL ACTIVITY AGAINST INFLUENZA VIRUS OF TYPE A (VERSIONS) | 2013 |
|
RU2551316C1 |
| MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
| STRAIN OF SERRATIA SPECIES BACTERIA HAVING ANTIVIRAL ACTIVITY | 2017 |
|
RU2650762C1 |
| INHIBITOR OF INFLUENZA A VIRUS REPRODUCTION BASED ON EXTRACT OF BASIDIAL FUNGUS Laetiporus sulphureus | 2011 |
|
RU2475530C2 |
| ANTIVIRAL MEDICATION BASED ON NEMATOPHAGOUS FUNGUS Duddingtonia flagrans | 2011 |
|
RU2475531C2 |
| Aeromonas bestiarum BACTERIA STRAIN - PRODUCER OF ALKALINE RIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2520086C1 |
